| Multiple Sclerosis |
1 |
1 |
| Meta-Analysis |
0 |
0.73 |
| Cardiometabolic Risk Factors |
0 |
0.56 |
| Hypertension |
0 |
0.38 |
| Cerebrovascular Accident |
0 |
0.31 |
| Disability |
0 |
0.31 |
| Hospital |
0 |
0.31 |
| Coronary Artery Disease (CAD) |
0 |
0.29 |
| Cerebrovascular Disease |
0 |
0.21 |
| Heart |
0 |
0.21 |
| Weakness |
0 |
0.21 |
| Anxiety Disorder |
0 |
0.16 |
| Asthma |
0 |
0.16 |
| Chronic Obstructive Pulmonary Disease |
0 |
0.16 |
| Depression |
0 |
0.16 |
| Lipids Management |
0 |
0.16 |
| Peripheral Artery Disease |
0 |
0.16 |
| Anxiety |
0 |
0.1 |
| Biostatistics |
0 |
0.1 |
| Canada |
0 |
0.1 |
| Disease-Modifying Therapy |
0 |
0.1 |
| Geriatrics |
0 |
0.1 |
| Hyperlipidemia |
0 |
0.1 |
| Lung |
0 |
0.1 |
| Mental Illness |
0 |
0.1 |
| Multiple Sclerosis Progression |
0 |
0.1 |
| Texas |
0 |
0.1 |